|
Formula |
CAS |
|
C12H17NO3 |
2438-72-4 |
CAS: Chemical Abstract Service Registry Number
Background
Bufexamac is used topically for the treatment of inflammation of the skin.
Synonyms
Bufexamac
4-Butoxy-N-hydroxybenzeneacetamide
2-(p-Butoxyphenyl)acetohydroxamic acid
2-[p-(Butyloxy)phenyl]acetohydroxamic acid
CP 1044 J3
Droxarol
Droxaryl
Feximac
Malipuran
Mofenar
Norfemac
Parfenac
Parfenal
Uses
Anti-inflammatory
Analgesic
Antipyretic
Hemorrhoids
Topical medications
Pharmaceuticals
Cross-Reactions
Unusual Reactions
Erythema multiforme-like eruption
Papular urticaria
Baboon syndrome
References
|
1. |
Christiansen, J.V., et al., Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial. Dermatologica, 1977. 154(3): p. 177-84. |
|
2. |
Reiffers, J., Contact dermatitis to bufexamac. Dermatologica, 1982. 164(5): p. 354-6. |
|
3. |
Watanabe, K. and K. Yoshikawa, Contact dermatitis due to bufexamac. Contact Dermatitis, 1983. 9(5): p. 433. |
|
4. |
Melino, M., F. Bardazzi, and P. Manuzzi, Contact dermatitis due to bufexamac. Contact Dermatitis, 1987. 16(5): p. 287. |
|
5. |
Perret, C.M. and R. Happle, Contact allergy to bufexamac. Contact Dermatitis, 1989. 20(4): p. 307-8. |
|
6. |
Corazza, M., C. Roveggio, and A. Virgili, Allergic contact dermatitis from bufexamac cream. Contact Dermatitis, 1993. 29(4): p. 219. |
|
7. |
Koch, P. and F.A. Bahmer, Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases. Contact Dermatitis, 1994. 31(2): p. 97-101. |
19-06-2011
(JRM) - www.huidziekten.nl